Mohammed A Al-Hamzi
Overview
Explore the profile of Mohammed A Al-Hamzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alraddadi B, Heaphy E, Aljishi Y, Ahmed W, Eljaaly K, Al-Turkistani H, et al.
BMC Infect Dis
. 2022 Jun;
22(1):542.
PMID: 35698046
Background: The burden of carbapenem resistance is not well studied in the Middle East. We aimed to describe the molecular epidemiology and outcome of carbapenem-resistant Enterobacterales (CRE) infections from several...
2.
Yamani A, Alraddadi B, Almaghrabi R, Amer A, Mehdawi F, Al-Hamzi M, et al.
Immun Inflamm Dis
. 2022 Jan;
10(3):e587.
PMID: 35029324
Background: Tocilizumab was studied to reduce cytokine syndrome in patients with severe COVID-19 pneumonia in solid organ transplant (SOT) recipients with conflicting results. We aim to study the early use...
3.
Alshukairi A, Tolah A, Dada A, Al-Tawfiq J, Almagharbi R, Saeedi M, et al.
Int J Infect Dis
. 2021 May;
108:112-115.
PMID: 34004329
Background: Immunocompromised patients with coronavirus disease 2019 (COVID-19) have prolonged infectious viral shedding for more than 20 days. A test-based approach is suggested for de-isolation of these patients. Methods: The...
4.
Ahmed W, Dada A, Alshukairi A, Sohrab S, Faizo A, Tolah A, et al.
J King Saud Univ Sci
. 2021 Feb;
33(3):101366.
PMID: 33613011
Objective: The new coronavirus disease 2019 (COVID-19) is a major health problem worldwide. The surveillance of seropositive individuals serves as an indicator to the extent of infection spread and provides...